The Gujarat Kidney IPO saw strong demand, ending with a 5.21‑times subscription and retail investors bidding 19 times their allotted share.
Subscription Highlights
During the three‑day bidding period, investors applied for 6.89 crore shares against the 1.32 crore shares offered, giving an overall subscription of 5.21 times.
- Retail individual investors: quota subscribed 19 times.
- Non‑institutional investors: quota subscribed 5.73 times.
- Qualified institutional buyers (QIBs): fully subscribed at 1.06 times.
IPO Details and Use of Funds
Key facts about the issue:
- Issue size: ₹250.80 crore (fresh issue of 2.20 crore shares).
- Price band: ₹108 – ₹114 per share.
- Planned use of proceeds: acquire Parekhs Hospital, fund capital expenditures, repay debt, and support general corporate purposes.
Allotment, Refunds and Listing Timeline
- Allotment finalisation: expected on Friday, 26 December.
- Refunds to unsuccessful applicants: start on Monday, 29 December.
- Shares credited to demat accounts: same day as refunds.
- Listing on NSE and BSE: tentatively on Tuesday, 30 December.
Grey Market Premium and Expected Listing Price
As of today, the grey market premium (GMP) is around ₹3 per share, hinting that the stock may list slightly above the issue price. Using the upper price band, the implied listing price is about ₹116, which is a 2.6 % premium.
Note: GMP is an informal indicator and should not be the sole basis for an investment decision.
About Gujarat Kidney
Gujarat Kidney operates a network of mid‑size multi‑specialty hospitals in central Gujarat, focusing on secondary and tertiary care.
- Seven multi‑specialty hospitals.
- Four pharmacy outlets.
- Total bed capacity: 490 (approved 455, operational 340).
Disclaimer
Remember, this is my perspective, not a prediction. Always do your own research or consult a certified financial expert before making any investment decisions.